A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
In this research, the authors established the role of fractalkine as a marker of inflammatory activity at concomitant respiratory cardiac pathology, which flows with potentization of systemic inflammatory reactions. We found that in patients with arterial hypertension (AH), and in patients with chronic obstructive pulmonary disease (COPD) activation of systemic inflammation is occured, more expressed in patients with COPD. At the same time, the development of AH in patients with COPD is notdoi:10.25207/1608-6228-2014-1-31-33 doaj:f1d829b9eef64638b406bbe823c3cba8 fatcat:afegesr6engaxif3osdmnzoh3y